BioClinica Launches Websend and Creates Efficiencies for Clinical Trial Imaging Delivery
BioClinica™, Inc., (NASDAQ: BIOC) announced the release of BioClinica WebSend, a system that simplifies and accelerates image collection for clinical studies. WebSend transfers and tracks medical images in real-time, offering fast delivery of image data and enhanced data quality with fewer site queries.
BioClinica WebSend is complemented by BioClinica WebView, a solution for managing the electronic sharing, blinding, tracking, archiving and analysis of medical images for clinical trials worldwide.
“BioClinica WebSend allows any investigator site or imaging center globally to send all medical images to BioClinica electronically in a secure, regulatory-compliant manner. Along with BioClinica WebView, WebSend manages the collection and validation of those images,” said Mark L. Weinstein, CEO of BioClinica, Inc.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
